SQuID (subcutaneous insulin in diabetic ketoacidosis) II: Clinical and operational effectiveness.

Richard T GriffeyRyan M SchneiderMargo GirardiGina LaRossaJulianne YearyMichael LehmkuhlLaura FrawleyRachel AnconaTaylor KaserDan SuarezPaulina Cruz-Bravo

Published in: Academic emergency medicine : official journal of the Society for Academic Emergency Medicine (2024)

In this single-center study, we observed excellent fidelity, equivalent or superior safety, and clinical and operational effectiveness with SQuID compared to IV insulin. The SQuID protocol has become the de facto default pathway for treatment of LTM DKA. Since inception of SQuID, ICU admissions in LTM DKA have decreased 33%.

Keyphrases

type diabetes
randomized controlled trial
systematic review
intensive care unit
glycemic control
mechanical ventilation
insulin resistance
weight loss